Treatment for Low Ceruloplasmin (Hypoceruloplasminemia)

Diagnostic Considerations Before Treatment

The American Association for the Study of Liver Diseases recommends that low ceruloplasmin levels be evaluated to determine the underlying cause, with Wilson's disease being a significant condition requiring copper chelation therapy with medications like D-penicillamine or trientine 1, 2
The European Association for the Study of the Liver suggests that Wilson's disease requires specific copper-reducing treatments 1, 3
Other conditions with low ceruloplasmin may require different management approaches, as recommended by the American Association for the Study of Liver Diseases 4

The American Association for the Study of Liver Diseases recommends confirming low ceruloplasmin levels (<200 mg/L or <20 mg/dL) 1
An extremely low level (<50 mg/L or <5 mg/dL) strongly suggests Wilson's disease, according to the European Association for the Study of the Liver 3

The American Association for the Study of Liver Diseases recommends first-line treatment with D-penicillamine, with an initial dosage of 250 mg/day, gradually increasing to 0.75-1.5 g/day 5
The European Association for the Study of the Liver suggests monitoring 24-hour urinary copper excretion (target: >2 mg in first week) and long-term monitoring of free serum copper <10 μg/dL 5, 4
The American Association for the Study of Liver Diseases recommends maintaining clinical and laboratory improvement, with urinary copper excretion: 3-8 μmol per 24h on treatment 4

The American Association for the Study of Liver Diseases recommends copper supplementation, particularly important in patients receiving parenteral nutrition without trace elements 1

The European Association for the Study of the Liver warns that up to 50% of Wilson's disease patients may experience worsening of neurological symptoms during initial D-penicillamine treatment 5

Low ceruloplasmin levels (<200 mg/L or <20 mg/dL) should be thoroughly evaluated to determine the underlying cause, with levels <50 mg/L or <5 mg/dL strongly suggesting Wilson's disease and requiring immediate attention 6
Confirm diagnosis with additional tests including 24-hour urinary copper excretion, serum free copper, and slit-lamp examination for Kayser-Fleischer rings 7

Low ceruloplasmin may occur in conditions other than Wilson's disease, including protein loss, severe end-stage liver disease, copper deficiency, Menkes disease, and Aceruloplasminemia 8

For copper deficiency, copper supplementation is indicated, particularly in patients receiving parenteral nutrition without trace elements, with monitoring for improvement in ceruloplasmin levels and resolution of associated symptoms 8
For Aceruloplasminemia, focus on managing iron overload rather than copper levels, as these patients exhibit hemosiderosis rather than copper accumulation 8, 7